Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
Clinical trial NCT01009255 · COMPLETED
Trial details
- NCT number
- NCT01009255
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-02
- Primary completion
- 2010-11-10
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.